Gerbes, Alexander L.; Labenz, Joachim; Appenrodt, Beate et al.
Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 57. H. 5. 2019 S. 611-680
Moehler, Markus
Updated S3 Guideline for Gastric Cancer now publishedZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 57. H. 12. 2019 S. 1515-1516
Labenz, Christian; Beul, Larissa; Toenges, Gerrit et al.
Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathyEUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 60. 2019 S. 96-100
Gehrke, Nadine; Biedenbach, Jana; Huber, Yvonne et al.
Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLDSCIENTIFIC REPORTS. Bd. 9. 2019
Pfirrmann, Daniel; Huber, Yvonne; Schattenberg, Joern Markus et al.
Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention StudyJOURNAL OF MEDICAL INTERNET RESEARCH. Bd. 21. H. 1. 2019
Simon, Perikles; Huber, Yvonne; Ptirrmann, Daniel et al.
Web-based Individualized Exercise Intervention Improves Physical Performance and Hepatic Inflammation in Patients with NAFLDMEDICINE AND SCIENCE IN SPORTS AND EXERCISE. Bd. 51. H. 6. 2019 S. 123-123
Wei, Teng; Weiler, Sofia Maria Elisabeth; Toth, Marcell et al.
YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cellsONCOGENE. Bd. 38. H. 27. 2019 S. 5541-5550
Kahaly, George J.; Bartalena, Luigi; Hegedus, Lazlo et al.
2018 European Thyroid Association Guideline for the Management of Graves' HyperthyroidismEUROPEAN THYROID JOURNAL. Bd. 7. H. 4. 2018 S. 167-186
Doria, A.; Bass, D.; Schwarting, A. et al.
A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosusLUPUS. Bd. 27. H. 9. 2018 S. 1489-1498
Czauderna, C.; Koch, S.; Pilz, L. et al.
A high alpha-fetoprotein slope prior to therapy correlates with poor prognosis of patients with hepatocellular carcinomasJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S442-S442